Home › Relapsing-Remitting Multiple Sclerosis › Texas
Relapsing-Remitting Multiple Sclerosis clinical trials in Texas
4 studies for Relapsing-Remitting Multiple Sclerosis are looking for participants at sites in Texas.
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)
- University of Texas Southwestern Medical Center: Division of Multiple Sclerosis and Neuroimmunology, Dallas
- Maxine Mesigner Multiple Sclerosis Comprehensive Care Center, Baylor College of Medicine Medical Center, Houston
RecruitingPhase 3
Ages 18 to 55 · All sexes · Updated Sep 16, 2026 · NCT04047628Treatment of Cognitive Deficits in Multiple Sclerosis With High-Definition Transcranial Direct Current Stimulation
- The University of Texas at Dallas, Richardson
Recruiting
Ages 18 to 65 · All sexes · Updated Sep 15, 2026 · NCT05958381Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis
- Local Institution - 0133, El Paso
RecruitingPhase 3
Ages 10 to 17 · All sexes · Updated Sep 10, 2026 · NCT06408259The SetPoint System as a Pro-Remyelination Therapy for Relapsing-Remitting Multiple Sclerosis: A Pilot Study
- The University of Texas at Austin, Austin
- The University of Texas Health Science Center at Houston, Houston
Recruiting
Ages 22 to 60 · All sexes · Updated Sep 2, 2026 · NCT06796504From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.